Arachidonic Acid Metabolites Contribute to the Irreversible Depolarization Induced by In Vitro Ischemia

Journal of Neurophysiology

Volumn 90, Issue 5, 2003, Pages 3213-3223

  Tanaka, E ^a   Niiyama, S ^a   Sato, S ^a   Yamada, A ^a   Higashi, H ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 17 OCTADECYNOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; 3,4 DIHYDROPHENYL ETHANOL; 4 BROMOPHENACYL BROMIDE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ALPHA TOCOPHEROL; ARACHIDONIC ACID; CYTOCHROME P450 INHIBITOR; GLUCOSE; INDOMETACIN; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; NORPHENAZONE; OXYGEN; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; IN VITRO STUDY; ISCHEMIA; LATENT PERIOD; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; METABOLITE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; ARACHIDONIC ACID; CELL HYPOXIA; ENZYME INHIBITORS; HIPPOCAMPUS; MALE; NEURONS; RATS; RATS, WISTAR;

EID: 0242425668     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00542.2003     Document Type: Article

References (69)

1. Aktan S, Aykut C, and Ercan S. Leukotriene C4 and prostaglandin E2 activities in the serum and cerebrospinal fluid during acute cerebral ischemia. Prostaglandins Leukot Essent Fatty Acids 43: 247-249, 1991.
2. Alkayed NJ, Narayanan J, Gebremedhim D, Medhora M, Roman RJ, and Harder DR. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke 27: 971-979, 1996.
3. Amruthesh SC, Boershel MF, McKinney JS, Willoughby KA, and Ellis EF. Metabolism of arachidonic acid to epoxyeicosatrienoic acids, hydroxy-eicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes. J Neurochem 61: 150-159, 1993.
4. Arai K, Ikegaya Y, Nakatani Y, Kudo I, Nishiyama N, and Matsuki N. Phospholipase A2 mediates ischemic injury in the hippocampus: a regional difference of neuronal vulnerability. Eur J Neurosci 13: 2319-2323, 2001a.
5. Arai K, Nishiyama N, Matsuki N, and Ikegaya Y. Neuroprotective effects of lipoxygenase inhibitors against ischemic injury in rat hippocampal slice cultures. Brain Res 904: 167-172, 2001b.
6. Aronica E, Nicoletti F, and Canonico PL. Activation of excitatory amino acid receptors increases intracellular free [3H]arachidonate levels in cultured cerebellar neurons. Funct Neurol 5: 15-20, 1990.
7. Barth A, Bauer R, Gedrange T, Walter B, Linss C, and Klinger W. Influence of hypoxia and hyperthermia upon peroxidative and glutathione status in growth-restricted newborn piglets. Exp Toxicol Pathol 50: 31-33, 1998.
8. Bazan NGJ. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochem Biophys Acta 218: 1-10, 1970.
9. Bondy SC and Naderi S. Contribution of hepatic cytochrome P-450 systems to the generation of reactive oxygen species. Biochem Pharmacol 48: 155-159, 1994.
10. Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA, and Sapirstein A. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390: 622-625, 1997.
11. Brierley JB and Graham DI. Hypoxia and vascular disorders of the central nervous system. In: Greenfield's Neuropathology (4th ed.), edited by Adams JH, Corsellis JAN, and Duchen LW. London, UK: Edward Arnold, 1984, p. 125-207.
12. Brown AW and Brierley JB. The nature, distribution and earliest stages of anoxic-ischaemic nerve cell damage in the rat brain as defined by the optical microscope. Br J Exp Pathol 49: 87-106, 1968.
13. Burton GW and Ingold KU. Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function. Acc Chem Res 19: 194-201, 1986.
14. Bylund J, Zhang C, and Harder DR. Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. Biochem Biophys Res Commun 296: 677-684, 2002.
15. Candelario-Jalil E, Alvarez D, Castaneda JM, Al-Dalain SM, Martinez-Sanchez G, Merino N, and Leon OS. The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils. Brain Res 927: 212-215, 2002.
16. Dorman RV, Hamm TF, Damron DS, and Freeman EJ. Modulation of glutamate release from hippocamapl mossy fiber nerve endings by arachidonic acid and eicosanoids. Adv Exp Med Biol 318: 121-136, 1992.
17. Elion GB. Enzymatic and metabolic studies with allopurinol. Ann Rheum Dis 25: 608-614, 1966.
18. Farooqui AA, Yang H-C, Rosenberger TA, and Horrocks LA. Phospholipase A2 and its role in brain tissue. J Neurochem 69: 889-901, 1997.
19. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, and Busse R. Endothelium-derived hyperpolarizing factor synthase (cytochrome P-450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88: 44-51, 2001.
20. Freeman EJ, Terrian DM, and Dorman RV. Presynaptic facilitation of glutamate release from isolated hippocampal mossy fiber nerve endings by arachidonic acid. Neurochem Res 15: 743-750, 1990.
21. Fukazawa K and Gebicki JM. Oxidation of α-tocopherol in micelles and liposomes by the hydroxyl, perhydroxyl, and superoxide free radicals. Arch Biochem Biophys 226: 242-251, 1983.
22. Govoni S, Masoero E, Favalli L, Rozza A, Scelsi R, Viappiani S, Buccellati C, Sala A, and Folco G. The cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neurosci Lett 303: 91-94, 2001.
23. Hansen AJ. The extracellular potassium concentration in brain cortex following ischemia in hypo- and hyperglycemic rats. Acta Physiol Scand 102: 324-329, 1978.
24. Hansen AJ. Effect of anoxia on ion distribution in the brain, Physiol Rev 65: 101-148, 1985.
25. Hara K, Kong DL, Sharp FR, and Weinstein PR. Effect of selective inhibition of cyclooxygenase 2 on temporary focal cerebral ischemia in rats. Neurosci Lett 256: 53-56, 1998.
26. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, and Ross ME. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 98: 1294-1299, 2001.
27. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, and Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
28. Kargman S, Wong E, Greig GM, Falgueyret J-P, Cromlish W, Ethier D, Yergey JA, Riendeau D, Evans JF, Kennedy B, Tagari P, Francis DA, and O'Neill GP. Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells. Biochem Pharmacol 52: 1113-1125, 1996.
29. Kohyama N, Nagata T, Fujimoto S, and Sekiya K. Inhibition of arachidonate lipoxygenase activities by 2-(3,4-dihydroxyphenyl)ethanol, a phenolic compound from olives. Biosci Biotech Biochem 61: 347-350, 1997.
30. Kontos HA. Oxygen radicals in cerebral ischemia: the 2001 Willis lecture. Stroke 32: 2712-2716, 2001.
31. Kukreja RC, Kontos HA, Hess ML, and Ellis EF. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 59: 612-619, 1986.
32. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, and Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsterodal anti-inflammatory drugs. J Pharmacol Exp Ther 271: 927-934, 1994.
33. Lazarewicz JW, Wroblewski JT, Palmer ME, and Costa E. Activation of N-methyl-D-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology 27: 765-769, 1988.
34. Leão AAP. Further observations on spreading depression of activity in the cerebral cortex. J Neurophysiol 10: 409-414, 1947.
35. Mattia CJ, Adams JD, and Bondy SC. Free radical induction in the brain and liver by products of toluene catabolism. Biochem Pharmacol 46: 103-110, 1993.
36. Miettinen S, Fusco FR, Yrjänheikki J, Keinänen R, Hirvonen T, Roivainen R, Närhi M, Hökfelt T, and Koistinaho J. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci USA 94: 6500-6505, 1997.
37. Montoliu C, Valles S, Renau-Piqueras J, and Guerri C. Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alchol consumption. J Neurochem 63: 1855-1862, 1994.
38. Moskowitz MA, Kiwak KJ, Hekimian L, and Levine L. Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion. Science 224: 886-889, 1984.
39. Nishikimi M, Yamada H, and Yagi K. Oxidation by superoxide of tocopherols dispersed in aqueous media with deoxycholate. Biochim Biophys Acta 627: 101-108, 1980.
40. Nogawa S, Zhang F, Ross ME, and Iadeeola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17: 2746-2755, 1997.
41. Ohtsuki T, Kitagawa K, Yamagata K, Mandai K, Mabuchi T, Matsushita K, Yanagihara T, and Matsumoto M. Induction of cyclooxygenase-2 mRNA in gerbil hippocampal neurons after transient forebrain ischemia. Brain Res 736: 353-356, 1996.
42. Ohtsuki T, Matsumoto M, Hayashi Y, Yamamoto K, Kitagawa K, Ogawa S, Yamamoto S, and Kamada T. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am J Physiol Heart CircPhysiol 268: H1249-H1257, 1995.
43. Onitsuka M, Mihara S, Yamamoto S, Shigemori M, and Higashi H. Nitric oxide contributes to irreversible membrane dysfunction caused by experimental ischemia in rat hippocampal CA1 neurons. Neurosci Res 30: 7-12, 1998.
44. Paller MS and Jacob HS. Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci USA 91: 7002-7006, 1994.
45. Pulsinelli WA and Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10: 267-272, 1979.
46. Pulsinelli WA, Brierley JB, and Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11: 491-498, 1982.
47. Puntarulo S and Cederbaum AI. Production of reactive oxygen speices by microsomes enriched in specific human cytochrome P-450 enzymes. Free Radical Biol Med 24: 1324-1330, 1998.
48. Rader RK and Lanthorn TH. Experimental ischemia induces a persistent depolarization blocked by decreased calcium and NMDA antagonists. Neurosci Lett 99: 125-130, 1989.
49. Rao AM, Hatcher JF, Kindy MS, and Dempsey RJ. Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem Res 24: 1225-1232, 1999.
50. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
51. Rosenthal MD, Vishwanath BS, and Franson RC. Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils. Biochem Biophys Acta 1001: 1-8, 1989.
52. Salari H, Braquet P, and Borgeat P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leuk Med 13: 53-60, 1984.
53. Sapirstein A and Bonventre JV. Phospholipase A2 in ischemic and toxic brain injury. Neurochem Res 25: 745-753, 2000.
54. Sasaki T, Nakagomi T, Kirino T, Tamura A, Noguchi M, Saito I, and Takakura K. Indomethacin ameliorates ischemic neuronal damage in the gerbil hippocampal CA1 sector. Stroke 19: 1399-1403, 1988.
55. Seibert K, Masferrer JL, Needleman P, and Salvemini D. Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney. Br J Pharmacol 117: 1016-1020, 1996.
56. Siesjö BK and Katsura K. Ischemic brain damage: focus on lipids and lipid mediators. In: Neurobiology of Essential Fatty Acids, edited by Bazan NG, Murphy MG, and Toffano G. New York: Plenum, 1992, p. 41-56.
57. Stevens MK and Yaksh TL. Time course of release in vivo of PGE2, PGF2α, 6-keto-PGF1α, and TXB2 into the brain extracellular space after 15 min of complete global ischemia in the presence and absence of cyclooxygenase inhibition. J Cereb Blood Flow Metab 8: 790-798, 1988.
58. Tanaka E, Yamamoto S, Inokuchi H, Isagai T, and Higashi H. Membrane dysfunction induced by in vitro ischemia in rat hippocampal CA1 pyramidal neurons. J Neurophysiol 81: 1872-1880, 1999.
59. Tanaka E, Yamamoto S, Kudo Y, Mihara S, and Higashi H. Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro. J Neurophysiol 78: 891-902, 1997.
60. Tanaka M. Pharmacological and clinical profile of the free radical scavemger edaravone as a neuroprotective agent. Nippon Yakurigaku Zasshi 119: 301-308, 2002.
61. Thompson CM, Capdevila JH, and Strobel HW. Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exp Ther 294: 1120-1130, 2000.
62. 2+ exchanger activity induces a slow DC potential after in vitro ischemia in rat hippocampal CA1 region. Neurosci Res 36: 129-140, 2000
63. Volterra A, Trotti D, Cassutti P, Tromba C, Galimberti R, Lecchi P, and Racagni G. A role for the arachidonic acid cascade in fast synaptic modulation: ion channels and transmitter uptake systems as target proteins. Adv Exp Med Biol 318: 147-158, 1992a.
64. Volterra A, Trotti D, Cassutti P, Tromba C, Salvaggio A, Meleangi RC and Racagni G. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J Neurochem 59: 600-606, 1992b.
65. Wang M-H, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, and Schwartzman ML. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther 284: 966-973, 1998.
66. Yamagata K, Andreasson KI, Kaufman WE, Barnes CA, and Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11: 371-386, 1993.
67. Yamamoto S, Tanaka E, Shoji Y, Kudo Y, Inokuchi H, and Higashi H. Factors that reverse the persistent depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro. J Neurophysiol 78: 903-911, 1997.
68. Zalkin H and Tappel AL. Studies of the mechanism of vitamin E action. IV. Lipid peroxydation in the vitamin E-deficient rabbit, Arch Biochem Biophys 88: 113-117, 1960.
69. Zou A-P, Ma Y-H, Sui Z-H, Ortiz de Montellano PR, Clark JE, Masters BS, and Roman RJ. Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function in rats. J Pharmacol Exp Ther 268: 474-481, 1994.